The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 5, 2015, Pages 467-476

  Lau, K ^a,b   Baumeister, S E ^a   Lieb, W ^c   Meffert, P J ^a   Lerch, M M ^a   Mayerle, J ^a   Volzke H ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE DEFICIENT TRANSFERRIN; HEMOGLOBIN A1C; BIOLOGICAL MARKER; CARBOHYDRATE-DEFICIENT TRANSFERRIN; TRANSFERRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BINGE DRINKING; BLOOD SAMPLING; BODY MASS; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ECHOGRAPH; ECHOGRAPHY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPEAN; FATTY LIVER; FEMALE; GERMANY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LASER NEPHELOMETER; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OBESITY; PHOTOMETER; PHOTOMETRY; PHYSICAL INACTIVITY; POPULATION RESEARCH; SELF REPORT; SPECTROPHOTOMETER; SPECTROPHOTOMETRY; VENOUS BLOOD; AGED; ANALOGS AND DERIVATIVES; BLOOD; DOSE RESPONSE; EUROPE; HEALTH BEHAVIOR; MIDDLE AGED; MORPHOMETRICS; RISK; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; ALCOHOL DRINKING; BINGE DRINKING; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; FATTY LIVER; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; RISK FACTORS; SELF REPORT; SEX FACTORS; TRANSFERRIN;

EID: 84921855619     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13067     Document Type: Article

References (27)

1. Souza MR, Diniz Mde F, Medeiros-Filho JE, et al,. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012; 49: 89-96.
2. Caballeria L, Auladell MA, Toran P, et al,. Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units. BMC Gastroenterol 2007; 7: 41.
3. Yamada T, Fukatsu M, Suzuki S, et al,. Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup. Dig Dis Sci 2010; 55: 176-82.
4. Gunji T, Matsuhashi N, Sato H, et al,. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 2009; 104: 2189-95.
5. Hiramine Y, Imamura Y, Uto H, et al,. Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol 2011; 46: 519-28.
6. Moriya A, Iwasaki Y, Ohguchi S, et al,. Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011; 33: 378-88.
7. Hamaguchi M, Kojima T, Ohbora A, et al,. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012; 18: 156-67.
8. Nishioji K, Sumida Y, Kamaguchi M, et al,. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012. J Gastroenterol 2014; doi: 10.1007/s00535-014-0948-9 [Epub ahead of print].
9. Mathurin P, Deltenre P,. Effect of binge drinking on the liver: an alarming public health issue? Gut 2009; 58: 613-7.
10. Alatalo PI, Koivisto HM, Hietala JP, et al,. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 2008; 88: 1097-103.
11. Ruhl CE, Everhart JE,. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005; 3: 1260-8.
12. Shen Z, Li Y, Yu C, et al,. A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels. Eur J Gastroenterol Hepatol 2010; 22: 820-5.
13. Volzke H, Alte D, Schmidt CO, et al,. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2010; 40: 294-307.
14. White IR, Royston P, Wood AM,. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011; 30: 377-99.
15. Baumeister SE, Alte D, Meyer C, et al,. Riskanter Alkoholkonsum und alkoholbezogene Störungen im Vorpommern: Die Studie "Leben und Gesundheit in Vorpommern" (SHIP) und der Bundesgesundheitssurvey 1998 im Vergleich. Gesundheitswesen 2005; 67: 39-47.
16. Bühringer G, Augustin R, Bergmann E, et al,. Alkoholkonsum und Alkoholbezogene Störungen in Deutschland [Alcohol Consumption and Alcoholrelated Problems in Germany]. Baden-Baden: Nomos Verlagsgesellschaft, 2000.
17. WHO. International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva: World Health Organization, 2000.
18. Naimi TS, Brewer RD, Mokdad A, et al,. Binge drinking among US adults. JAMA 2003; 289: 70-5.
19. WHO. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation. WHO technical report Series 894. Geneva: World Health Organization, 2000.
20. Desquilbet L, Mariotti F,. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010; 29: 1037-57.
21. Greenland S, Pearl J, Robins JM,. Causal diagrams for epidemiologic research. Epidemiology 1999; 10: 37-48.
22. Arndt T,. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001; 47: 13-27.
23. De Vries JHM, Lemmens PH, Pietinen P, et al,. Assessment of alcohol consumption. In:, Macdonald I, ed. Health Issues Related to Alcohol Consumption. Oxford: Blackwell Sience Ltd, 1999; 27-62.
24. Vernon G, Baranova A, Younossi ZM,. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-85.
25. Morini L, Varango C, Filippi C, et al,. Chronic excessive alcohol consumption diagnosis: comparison between traditional biomarkers and ethyl glucuronide in hair, a study on a real population. Ther Drug Monit 2011; 33: 654-7.
26. Fagan KJ, Irvine KM, McWhinney BC, et al,. Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers. BMC Gastroenterol 2014; 14: 97.
27. Bellentani S, Saccoccio G, Masutti F, et al,. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7.